应用[18F]AlF-NOTA-FAPI-04 PET/CT评估甲状腺眼病纤维炎性活动的前瞻性研究
该前瞻性研究纳入23例甲状腺眼病患者和10例健康对照,行[18F]AlF-NOTA-FAPI-04 PET/CT,并以15例患者16份眼外肌病理为金标准。结果显示活动性眼外肌FAPI摄取弥漫性增高且TBR优良,SUVmax与病理纤维炎性评分正相关(r=0.68,P=.004),FAPI驱动评估的敏感度和特异度均为100%。作者认为该PET/CT可能是有前景的无创评估TED活动度的方法,可能优于CAS。
要点
- 病理活动性眼外肌SUVmax 9.57±2.79、TBR 2.99±1.00,高于非活动性眼外肌的4.04±1.02、1.00±0.35(均P<.001)。
- SUVmax截断值5.95预测活动性病变的ROC曲线下面积为0.98。
- FAPI驱动评估TED活动度的敏感度和特异度均为100%,CAS驱动评估分别为72.7%和100%。
核心结论
- 眼外肌弥漫性高FAPI摄取伴优良TBR可反映TED活动度,并与病理纤维炎性评分正相关。
- 作者认为[18F]AlF-NOTA-FAPI-04 PET/CT可能成为评估TED疾病活动度的有前景的可靠无创方法,可能优于CAS。
研究设计与样本
- 前瞻性研究,纳入23例TED患者和10例健康对照,行[18F]AlF-NOTA-FAPI-04 PET/CT。
- TED眼按临床活动度评分(CAS)分为活动性(CAS+)和非活动性(CAS-)。
- PET分析包括定性(FAPI+或FAPI-)和定量(每块眼外肌SUVmax和靶本比TBR)评估。
- 以15例TED眼共16份眼外肌样本的病理评估为金标准,评价CAS驱动和FAPI驱动评估的诊断准确度。
主要发现
- 基于眼的分析纳入42只TED眼和20只对照眼。
- CAS-/FAPI+眼(n=8)与CAS+/FAPI+眼(n=17)的SUVmax无显著差异;但两组SUVmax均显著高于CAS-/FAPI-眼(n=16)、CAS+/FAPI-眼(n=1)和对照眼(n=20)(均P<.05)。
- 病理活动性眼外肌呈弥漫性高FAPI摄取伴优良TBR,其SUVmax和TBR均高于非活动性眼外肌(SUVmax:9.57±2.79 vs. 4.04±1.02,TBR:2.99±1.00 vs. 1.00±0.35,均P<.001)。
- SUVmax截断值5.95预测活动性病变的受试者工作特征曲线下面积为0.98。
- CAS驱动和FAPI驱动评估TED活动度的敏感度和特异度分别为72.7%和100%、100%和100%。
关键数值与推荐
- SUVmax截断值5.95预测活动性病变的ROC曲线下面积为0.98。
- CAS驱动评估TED活动度的敏感度72.7%、特异度100%;FAPI驱动评估的敏感度100%、特异度100%。
- SUVmax与病理纤维炎性评分正相关(r=0.68,P=.004)。
临床怎么用
- 作者认为[18F]AlF-NOTA-FAPI-04 PET/CT可能作为评估TED疾病活动度的有前景的可靠无创方法,可能优于CAS。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study evaluates the value of [18F]AlF-NOTA-FAPI-04PET/CT in assessing the disease activity of thyroid eye disease (TED). METHODS: Twenty-three TED patients and ten healthy controls were prospectively recruited and underwent [18F]AlF-NOTA-FAPI-04 PET/CT scans. TED eyes were classified by Clinical Activity Score (CAS) as active (CAS +) or inactive (CAS-). PET analysis included qualitative and quantitative evaluations. Qualitative analysis categorized TED eyes as positive (FAPI +) or negative (FAPI-), while quantitative analysis including SUVmax and target-to-backgroud ratio (TBR) of each extraocular muscle (EOM). Pathological assessment of 16 EOM samples from 15 TED eyes was used as a gold standard to evaluate the diagnostic accuracy of CAS-driven and FAPI-driven assessments. RESULTS: Eye-based analysis included 42 TED eyes and 20 control eyes. SUVmax did not differ significantly between CAS-/FAPI + (n = 8) and CAS + /FAPI + (n = 17) eyes; though both groups had significantly higher SUVmax than CAS-/FAPI- (n = 16), CAS + /FAPI- (n = 1), and control eyes (n = 20) (all P < .05). Diffuse high FAPI uptake with excellent TBR was observed in pathologically active EOMs and had higher SUVmax and TBR than inactive EOMs (SUVmax: 9.57 ± 2.79 vs. 4.04 ± 1.02, TBR: 2.99 ± 1.00 vs. 1.00 ± 0.35, both P < .001). An SUVmax cutoff value of 5.95 yielded an area under the receiver operating characteristic curve of 0.98 for predicting active disease. Sensitivity and specificity of CAS-driven and FAPI-driven assessments for TED activity were 72.7% and 100%, 100% and 100%, respectively. SUVmax positively correlated with pathological fibroinflammatory score (r = 0.68, P = .004). CONCLUSION: The diffuse high FAPI uptake with excellent TBR in the EOMs could illustrate the activity of TED, positively correlated with pathological fibroinflammatory scores. These findings suggest that [18F]AlF-NOTA-FAPI-04 PET/CT may serve as a promising reliable non-invasive approach for assessing disease activity in TED, potentially superior to the CAS.
引用
- Li H, Wang Y, Zhou J, et al. Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study. Eur J Nucl Med Mol Imaging. 2024. PMID: 39671100. doi:10.1007/s00259-024-07015-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。